Tech Company Financing Transactions

Efficas Funding Round

Efficas closed a $2 million financing round on 6/30/2007. Backers included Life Sciences Partners, Prolog Ventures and Unilever.

Transaction Overview

Company Name
Announced On
6/30/2007
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
310 N Harbor Blvd. 205
Fullerton, CA 92832
USA
Email Address
Overview
Efficas is a consumer focused health-science and technology company committed to developing effective products for the nutritional management of the immune system for both humans and pets.
Profile
Efficas LinkedIn Company Profile
Social Media
Efficas Company Twitter Account
Company News
Efficas News
Facebook
Efficas on Facebook
YouTube
Efficas on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Mark Braman
  Mark Braman LinkedIn Profile  Mark Braman Twitter Account  Mark Braman News  Mark Braman on Facebook
VP - Operations
Robert Driver
  Robert Driver LinkedIn Profile  Robert Driver Twitter Account  Robert Driver News  Robert Driver on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2007: Corepair venture capital transaction
Next: 6/30/2007: Marathon Technologies venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record funding rounds that are announced publicly. All VC database entries reported here are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary